These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 31239661

  • 1. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW, Zhao P, Khan A, Raza F, Raza SM, Sarfraz M, Chen Y, Li M, Yang T, Ma X, Xiang G.
    Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y, Zhao P, Wu S, Yang T, Chen Y, Zhang X, He C, Zheng C, Li K, Ma X, Xiang G.
    Int J Pharm; 2018 Jul 10; 545(1-2):261-273. PubMed ID: 29730175
    [Abstract] [Full Text] [Related]

  • 3. Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles.
    Zhao P, Li M, Wang Y, Chen Y, He C, Zhang X, Yang T, Lu Y, You J, Lee RJ, Xiang G.
    Acta Biomater; 2018 May 10; 72():248-255. PubMed ID: 29555460
    [Abstract] [Full Text] [Related]

  • 4. Synergism of cisplatin-oleanolic acid co-loaded hybrid nanoparticles on gastric carcinoma cells for enhanced apoptosis and reversed multidrug resistance.
    Li D, Cui R, Xu S, Liu Y.
    Drug Deliv; 2020 Dec 10; 27(1):191-199. PubMed ID: 31924110
    [Abstract] [Full Text] [Related]

  • 5. MiR-375 delivered by lipid-coated doxorubicin-calcium carbonate nanoparticles overcomes chemoresistance in hepatocellular carcinoma.
    Zhao P, Wu S, Cheng Y, You J, Chen Y, Li M, He C, Zhang X, Yang T, Lu Y, Lee RJ, He X, Xiang G.
    Nanomedicine; 2017 Nov 10; 13(8):2507-2516. PubMed ID: 28577837
    [Abstract] [Full Text] [Related]

  • 6. Cisplatin and farnesol co-encapsulated PLGA nano-particles demonstrate enhanced anti-cancer potential against hepatocellular carcinoma cells in vitro.
    Mondal J, Khuda-Bukhsh AR.
    Mol Biol Rep; 2020 May 10; 47(5):3615-3628. PubMed ID: 32314187
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X, Bai H, Zhang X, Liu J, Cao P, Liao N, Zhang W, Wang Z, Hai C.
    Carcinogenesis; 2013 Jun 10; 34(6):1323-30. PubMed ID: 23404993
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux.
    Chen C, Ai QD, Wei YH.
    J Ethnopharmacol; 2021 Jan 10; 264():113388. PubMed ID: 32918990
    [Abstract] [Full Text] [Related]

  • 11. Antitumor effect of poly lactic acid nanoparticles loaded with cisplatin and chloroquine on the oral squamous cell carcinoma.
    Li Q, Liu X, Yan W, Chen Y.
    Aging (Albany NY); 2020 Dec 11; 13(2):2593-2603. PubMed ID: 33323546
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of cancer cell growth by oleanolic acid in multidrug resistant liver carcinoma is mediated via suppression of cancer cell migration and invasion, mitochondrial apoptosis, G2/M cell cycle arrest and deactivation of JNK/p38 signalling pathway.
    Gao C, Li X, Yu S, Liang L.
    J BUON; 2019 Dec 11; 24(5):1964-1969. PubMed ID: 31786862
    [Abstract] [Full Text] [Related]

  • 13. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y, Hu L, Huang S, Xu W, Wan J, Wang D, Zheng G, Xia Z.
    Int J Nanomedicine; 2018 Dec 11; 13():8309-8323. PubMed ID: 30584302
    [Abstract] [Full Text] [Related]

  • 14. [Oleanolic acid induces G₂/M phase arrest and apoptosis in human hepatocellular carcinoma Bel-7402 cells].
    Liu L, Zhao JL, Wang JG.
    Zhongguo Zhong Yao Za Zhi; 2015 Dec 11; 40(24):4897-902. PubMed ID: 27245040
    [Abstract] [Full Text] [Related]

  • 15. Liposomal co-delivered oleanolic acid attenuates doxorubicin-induced multi-organ toxicity in hepatocellular carcinoma.
    Sarfraz M, Afzal A, Raza SM, Bashir S, Madni A, Khan MW, Ma X, Xiang G.
    Oncotarget; 2017 Jul 18; 8(29):47136-47153. PubMed ID: 28525367
    [Abstract] [Full Text] [Related]

  • 16. A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.
    Bao X, Gao M, Xu H, Liu KX, Zhang CH, Jiang N, Chu QC, Guan X, Tian Y.
    Drug Dev Ind Pharm; 2015 Jul 18; 41(7):1193-203. PubMed ID: 25026246
    [Abstract] [Full Text] [Related]

  • 17. Identification of a novel oxidative stress induced cell death by Sorafenib and oleanolic acid in human hepatocellular carcinoma cells.
    Lange M, Abhari BA, Hinrichs TM, Fulda S, Liese J.
    Biochem Pharmacol; 2016 Oct 15; 118():9-17. PubMed ID: 27544320
    [Abstract] [Full Text] [Related]

  • 18. Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cells.
    Liese J, Abhari BA, Fulda S.
    Cancer Lett; 2015 Aug 28; 365(1):47-56. PubMed ID: 25917078
    [Abstract] [Full Text] [Related]

  • 19. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X, Chen Q, Li Y, Tang H, Liu W, Yang X.
    Eur J Pharm Biopharm; 2015 Jun 28; 93():27-36. PubMed ID: 25770771
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel-loaded nanoparticles decorated with bivalent fragment HAb18 F(ab')2 and cell penetrating peptide for improved therapeutic effect on hepatocellular carcinoma.
    Jin C, Bai L, Lin L, Wang S, Yin X.
    Artif Cells Nanomed Biotechnol; 2018 Aug 28; 46(5):1076-1084. PubMed ID: 28776396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.